BiOptic Inc., Giant Bio Technology Inc. and NTOU have jointly publised a journal article on MDPI
2022-02-17
According to the 2018 market survey report, the global farmed shrimp market is about 28 billion U.S. dollars. Due to the globalization and high-density of aquaculture industry, the spread of diseases has accelerated. Among them, shrimp infectious diseases will outbreak every few years, including white Spot disease (WSD), acute hepatopancreatic necrosis disease (AHPND), and hepatopancreatic microsporidia (HPM), which reduce the industry profit with an estimated $7.8 billion annually.
BiOptic Inc. was listed on Taiwan’s Emerging Stock Board from Q4, 2021
2021-12-28
BiOptic Inc.’s self-developed COVID-19 test kit has been formally submitted to the European Union a few days ago to apply for in vitro diagnostic medical device (CE-IVD) certification.
Congratulations! BiOptic has won the 28th Taiwan Small and Medium Enterprises Innovation Award!
2021-11-22
BiOptic has won the 28th Taiwan Small and Medium Enterprises Innovation Award for its "Qsep1-Lite Bio-Fragment Analyzer" from the Ministry of Economic Affairs, R.O.C.
【BiOptic x CatchGene Webinar】Biotechnologies of Automated High-Yield Capturing and Quality Control
2021-06-01
With the continuous development of molecular detection technology, circulating cell-free DNA (cfDNA), FFPE tissue DNA and stool DNA have become important targets. However, since cfDNA is rare, FFPE DNA is fragmental, and stool DNA is rich in inhibitors, it is a very laborious process to purify and perform quality control of these types of samples. .....
